Inpatient and Outpatient Orderable

OnkoSight Advanced Chronic Lymphoid Neoplasm

Synonyms

LAB12276
ONKOSIGHT ADVANCED CHRONIC LYMPHOID NEOPLASM
ONKOSIGHT ADVANCED CHRONIC LYMPHOID NEOPLASMA N
ONKOSIGHT ADVANCED CHRONIC LYMPHOID NEOPLASMA NGS
OSACLN

Cerner Name

OnkoSight Advanced Chronic Lymphoid Neoplasma NGS

Clinical Info

This test includes the following genes: ARID1A, ATM, B2M, BCL2, BIRC3, BRAF, BTK, CARD11, CCND1, CCND3,
CD79B, CDKN2A, CREBBP, CXCR4, DNMT3A, EP300, EZH2, FBXW7, FOXO1, IDH2, IRF4, JAK1, JAK3, KRAS,
MAP2K1, MAPK1, MEF2B, MYC, MYD88, NOTCH1, NOTCH2, NRAS, NSD2, PIK3CD, PIM1, PLCG2, PRDM1,
RHOA, SETD2, SF3B1, SOCS1, STAT3, STAT5B, STAT6, TCF3, TET2, TNFAIP3, TNFRSF14, TP53 and XPO1.

Specimen Sources

Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous Bone Marrow Bone Marrow Aspirate

Specimen Types

Aspirate Blood Bone Marrow

Specimen Volume

Volume
3-5 mL (blood), 1-2 mL (bone marrow)
Minimum Volume
3 mL (blood), 1 mL (bone marrow)

Container

Lavender Top Tube

Collection Instructions

Container
Lavender-top (EDTA) tube; green-top (sodium heparin) tube; cells left over from flow cytometry analysis,
either fresh cell suspension or fresh/frozen cell pellet spun down from suspension.
Cell suspension should be shipped on ice.
Causes for Rejection
Specimen does not meet criteria for sample type, container, minimum volume, collection and storage; frozen whole blood
or marrow; leaking tube; clotted blood or marrow; grossly hemolyzed specimen or otherwise visibly degraded; contaminated
specimen; contains suspicious foreign material

Transport Instructions

Room Temperature

Specimen Stability

Methodology

The Labcorp Myeloid NGS assay utilizes capture-based next generation sequencing of whole genomic DNA libraries
to identify gene alterations that have diagnostic, prognostic and therapeutic significance in lymphoid malignancies.

Days Performed

TAT: 10-14 Days

Performing Laboratory

Labcorp

CPT

81450

PDM

235442

Only Orderable at Locations:

Orderable Everywhere

Results

Component Name	Base Name	Common Name	External Name
GENES	GENES	GENES	Genes
SPECIMEN TYPE - LC	SPECTYPE	SPECIMEN TYPE	Specimen Type - LC
INDICATION	INDICATION	INDICATION	Indication
RESULT:	RESULT	RESULT	Result:
INTERPRETATION:	INTERP	INTERPRETATION	Interpretation:
COMMENTS (REF LAB)	COMMENTREF	COMMENTS REF LAB	Comments (Ref lab)
METHOD/LIMITATIONS	METHODLIMIT	METHOD LIMITATIONS	Method/Limitations
REFERENCES	REFERENCES	REFERENCES	References
RELEASED BY:	RELEASEDONK	RELEASED BY	Released By
REFERRING PHYSICIAN	REFMD	REFERRING PHYSICIAN	Referring Physician
APPENDIX-CLINICAL TRIALS	APPENDIXCT	APPENDIX CLINICAL TRIALS	Appendix-Clinical Trials
IMAGE	IMAGE	IMAGE	Image
ONKOSIGHT ADVANCED CHRONIC LYMPHOID NEOP	ONKOACHLYM	ONKOSIGHT ADVANCED CHRONIC LYMPHOID NEOP	OnkoSight Advanced Chronic Lymphoid Neop
THERAPEUTIC AND PROGNOSTIC ASSOCIATIONS	THERPROGASS	THERAPEUTIC AND PROGNOSTIC ASSOCIATIONS	Therapeutic and Prognostic Associations
INTERPRETATION SUMMARY	ONKOSIGHTINT	INTERPRETATION SUMMARY	Interpretation Summary
DETAILED GENETIC INTERPRETATION 1	DETAILGENINT	DETAILED GENETIC INTERPRETATION 1	Detailed Genetic Interpretation 1
DETAILED GENETIC INTERPRETATION 2 :	DETAILGENINT	DETAILED GENETIC INTERPRETATION 2	Detailed Genetic Interpretation 2 :
CLINICAL TRIALS 1 :	CLINTRIAL	CLINICAL TRIALS 1	Clinical Trials 1:
CLINICAL TRIALS 2 :	CLINTRIAL	CLINICAL TRIALS 2	Clinical Trials 2:
TECHNICAL SUMMARY :	TECHSUM	TECHNICAL SUMMARY	Technical Summary:
METHODS	METHODS	METHODS	Methods
REFERENCES 1	REF1	REFERENCES 1	References 1
REFERENCES 2	REF2	REFERENCES 2	References 2
REPORT FOOTER	RPTFOOTER	REPORT FOOTER	Report Footer
ADDENDUM :	ADDENDUM	ADDENDUM	Addendum:

Result Interpretation

See Report

Forms

LAB12276

Search: .supercomplete-item { width: 600px; white-space: nowrap; overflow: hidden; text-overflow: ellipsis; } $(document).ready(function() { $("#search_input").supercomplete(); });